• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖-海藻酸钠纳米粒子的抗菌和抗炎活性:一种针对皮肤病原体的靶向治疗方法。

Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens.

机构信息

Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

出版信息

J Invest Dermatol. 2013 May;133(5):1231-9. doi: 10.1038/jid.2012.399. Epub 2012 Nov 29.

DOI:10.1038/jid.2012.399
PMID:23190896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3631294/
Abstract

Advances in nanotechnology have demonstrated potential application of nanoparticles (NPs) for effective and targeted drug delivery. Here we investigated the antimicrobial and immunological properties and the feasibility of using NPs to deliver antimicrobial agents to treat a cutaneous pathogen. NPs synthesized with chitosan and alginate demonstrated a direct antimicrobial activity in vitro against Propionibacterium acnes, the bacterium linked to the pathogenesis of acne. By electron microscopy (EM) imaging, chitosan-alginate NPs were found to induce the disruption of the P. acnes cell membrane, providing a mechanism for the bactericidal effect. The chitosan-alginate NPs also exhibited anti-inflammatory properties as they inhibited P. acnes-induced inflammatory cytokine production in human monocytes and keratinocytes. Furthermore, benzoyl peroxide (BP), a commonly used antiacne drug, was effectively encapsulated in the chitosan-alginate NPs and demonstrated superior antimicrobial activity against P. acnes compared with BP alone while demonstrating less toxicity to eukaryotic cells. Together, these data suggest the potential utility of topical delivery of chitosan-alginate NP-encapsulated drug therapy for the treatment of dermatologic conditions with infectious and inflammatory components.

摘要

纳米技术的进步已经证明了纳米粒子(NPs)在有效和靶向药物输送方面的潜在应用。在这里,我们研究了 NPs 的抗菌和免疫特性,以及使用 NPs 将抗菌剂递送到治疗皮肤病原体的可行性。用壳聚糖和海藻酸钠合成的 NPs 在体外对痤疮丙酸杆菌具有直接的抗菌活性,痤疮丙酸杆菌与痤疮的发病机制有关。通过电子显微镜(EM)成像,发现壳聚糖-海藻酸钠 NPs 能够诱导 P. acnes 细胞膜的破坏,为杀菌作用提供了一种机制。壳聚糖-海藻酸钠 NPs 还表现出抗炎特性,因为它们抑制了人单核细胞和角质形成细胞中 P. acnes 诱导的炎性细胞因子的产生。此外,过氧化苯甲酰(BP),一种常用的抗痤疮药物,被有效地包裹在壳聚糖-海藻酸钠 NPs 中,与单独使用 BP 相比,对 P. acnes 具有更好的抗菌活性,同时对真核细胞的毒性更小。综上所述,这些数据表明,局部递送壳聚糖-海藻酸钠 NP 包封药物治疗具有感染和炎症成分的皮肤病的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/b09f3bdc9710/nihms410935f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/39ea5e7df781/nihms410935f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/cd4a01460c04/nihms410935f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/05d1934d6dee/nihms410935f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/c7d89b4efb43/nihms410935f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/b09f3bdc9710/nihms410935f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/39ea5e7df781/nihms410935f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/cd4a01460c04/nihms410935f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/05d1934d6dee/nihms410935f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/c7d89b4efb43/nihms410935f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/095c/3631294/b09f3bdc9710/nihms410935f5.jpg

相似文献

1
Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens.壳聚糖-海藻酸钠纳米粒子的抗菌和抗炎活性:一种针对皮肤病原体的靶向治疗方法。
J Invest Dermatol. 2013 May;133(5):1231-9. doi: 10.1038/jid.2012.399. Epub 2012 Nov 29.
2
Applications of nanoparticles for treating cutaneous infection.纳米粒子在治疗皮肤感染中的应用。
J Invest Dermatol. 2013 May;133(5):1133-5. doi: 10.1038/jid.2012.412.
3
Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.那氟沙星是一种抗痤疮喹诺酮类抗菌药物,可抑制人外周血单核细胞和正常人角质形成细胞产生促炎细胞因子。
J Dermatol Sci. 2005 Apr;38(1):47-55. doi: 10.1016/j.jdermsci.2005.01.002.
4
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.月桂酸对痤疮丙酸杆菌的抗菌特性:其对寻常性炎性痤疮的治疗潜力。
J Invest Dermatol. 2009 Oct;129(10):2480-8. doi: 10.1038/jid.2009.93. Epub 2009 Apr 23.
5
Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes.颗粒溶素衍生肽对痤疮丙酸杆菌具有抗菌和抗炎作用。
J Invest Dermatol. 2005 Aug;125(2):256-63. doi: 10.1111/j.0022-202X.2005.23805.x.
6
A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.一种理性设计的多功能抗生素,用于治疗耐药性痤疮。
J Invest Dermatol. 2018 Jun;138(6):1400-1408. doi: 10.1016/j.jid.2017.11.041. Epub 2018 Jan 31.
7
The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.CEN1HC-Br 对痤疮丙酸杆菌的抗菌作用及其对寻常痤疮的治疗和抗炎作用。
Peptides. 2018 Jan;99:36-43. doi: 10.1016/j.peptides.2017.11.001. Epub 2017 Nov 3.
8
Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.抗菌肽P5对小鼠痤疮丙酸杆菌感染及相关炎症反应的抑制作用
PLoS One. 2015 Jul 21;10(7):e0132619. doi: 10.1371/journal.pone.0132619. eCollection 2015.
9
Antibiotic resistance in the topical treatment of acne vulgaris.寻常痤疮局部治疗中的抗生素耐药性。
Cutis. 2004 Jun;73(6 Suppl):6-10.
10
Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.壳聚糖包被的海藻酸钠纳米颗粒用于靶向给药应用的有效方法。
J Biomater Appl. 2016 Jul;31(1):3-12. doi: 10.1177/0885328216648478. Epub 2016 May 9.

引用本文的文献

1
Evaluation of Anti-Inflammatory Effects of Chitosan Film Loaded Extract Through In Vitro and In Vivo Studies.通过体外和体内研究评估壳聚糖膜负载提取物的抗炎作用。
Arch Razi Inst. 2024 Dec 31;79(6):1271-1280. doi: 10.32592/ARI.2024.79.6.1271. eCollection 2024 Dec.
2
Therapeutic Potential of Alginate-Pectin-Chitosan Encapsulated Pediococcus acidilactici Against Bile Duct Ligation-Induced Hepatic Fibrosis in Rats.海藻酸钠-果胶-壳聚糖包封的嗜酸乳杆菌对胆管结扎诱导的大鼠肝纤维化的治疗潜力
Probiotics Antimicrob Proteins. 2025 Jun 27. doi: 10.1007/s12602-025-10625-z.
3
From Nanocrystals and Nanocomposites to Microcrystals: The Role of Simonkolleite/ZnO in Overcoming Bacterial Resistance and Ensuring Biocompatibility.

本文引用的文献

1
Effects of 420-nm intense pulsed light in an acne animal model.420nm 强脉冲光在痤疮动物模型中的作用。
J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1168-71. doi: 10.1111/j.1468-3083.2012.04487.x. Epub 2012 Feb 25.
2
The growing role of nanotechnology in combating infectious disease.纳米技术在防治传染病方面的作用日益增强。
Virulence. 2011 Sep-Oct;2(5):395-401. doi: 10.4161/viru.2.5.17035. Epub 2011 Sep 1.
3
Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate.壳聚糖微球用于维持硫酸米诺地尔的局部递送。
从纳米晶体和纳米复合材料到微晶:锌羟氯铅矿/氧化锌在克服细菌耐药性和确保生物相容性方面的作用。
ACS Omega. 2025 May 15;10(20):20117-20128. doi: 10.1021/acsomega.4c09594. eCollection 2025 May 27.
4
-Derived Chitosan: A Promising Immunomodulatory Agent for Applications in Biomedical Fields.脱乙酰壳多糖:一种在生物医学领域具有应用前景的免疫调节因子。
Biomacromolecules. 2025 May 12;26(5):3224-3233. doi: 10.1021/acs.biomac.5c00362. Epub 2025 Apr 29.
5
Antibiotic-Resistant : Current Challenges and Emerging Alternative Therapies.抗生素耐药性:当前挑战与新兴替代疗法
Microorganisms. 2025 Apr 16;13(4):913. doi: 10.3390/microorganisms13040913.
6
Simvastatin-Loaded Chitosan-Functionalized PLGA Nanoparticles: Characterization and Use in Intimal Hyperplasia Therapy.载辛伐他汀的壳聚糖功能化聚乳酸-羟基乙酸共聚物纳米粒:表征及其在内膜增生治疗中的应用
Pharmaceutics. 2025 Mar 20;17(3):391. doi: 10.3390/pharmaceutics17030391.
7
Recent advances of silver nanoparticle-based polymer nanocomposites for biomedical applications.用于生物医学应用的银纳米颗粒基聚合物纳米复合材料的最新进展。
RSC Adv. 2025 Mar 19;15(11):8480-8505. doi: 10.1039/d4ra08220f. eCollection 2025 Mar 17.
8
Potential Applications of Chitosan in Seborrheic Dermatitis and Other Skin Diseases: A Comprehensive Review.壳聚糖在脂溢性皮炎及其他皮肤病中的潜在应用:综述
Clin Cosmet Investig Dermatol. 2025 Mar 6;18:533-542. doi: 10.2147/CCID.S504778. eCollection 2025.
9
Evaluation of Antifungal Activity of MaxilloFacial Silicone Elastomer Reinforced with Chitosan Nanoparticles-An Study.壳聚糖纳米颗粒增强型颌面硅橡胶弹性体的抗真菌活性评估——一项研究
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S3239-S3241. doi: 10.4103/jpbs.jpbs_604_24. Epub 2024 Sep 5.
10
Nanolevel Immunomodulators in Sepsis: Novel Roles, Current Perspectives, and Future Directions.脓毒症中的纳米级免疫调节剂:新作用、当前观点和未来方向。
Int J Nanomedicine. 2024 Nov 23;19:12529-12556. doi: 10.2147/IJN.S496456. eCollection 2024.
J Microencapsul. 2011;28(7):650-8. doi: 10.3109/02652048.2011.604435. Epub 2011 Aug 9.
4
Chitosan/PLGA particles for controlled release of α-tocopherol in the GI tract via oral administration.壳聚糖/PLGA 粒子经口服用于胃肠道中 α-生育酚的控制释放。
Nanomedicine (Lond). 2011 Nov;6(9):1513-28. doi: 10.2217/nnm.11.44. Epub 2011 Jun 27.
5
Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant.寻常痤疮的发病机制:新进展、有趣之处及临床相关要点
J Drugs Dermatol. 2011 Jun;10(6):582-5.
6
Antimicrobial effect of chitosan nanoparticles on streptococcus mutans biofilms.壳聚糖纳米粒子对变形链球菌生物膜的抗菌作用。
Appl Environ Microbiol. 2011 Jun;77(11):3892-5. doi: 10.1128/AEM.02941-10. Epub 2011 Apr 15.
7
Combating antimicrobial resistance: policy recommendations to save lives.抗击抗菌素耐药性:拯救生命的政策建议。
Clin Infect Dis. 2011 May;52 Suppl 5(Suppl 5):S397-428. doi: 10.1093/cid/cir153.
8
In vitro antifungal activity and toxicity of itraconazole in DMSA-PLGA nanoparticles.伊曲康唑负载于二巯基丁二酸-聚乳酸-羟基乙酸共聚物纳米粒中的体外抗真菌活性及毒性
J Nanosci Nanotechnol. 2011 Mar;11(3):2308-14. doi: 10.1166/jnn.2011.3576.
9
Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study.玉米醇溶蛋白/壳聚糖复合纳米粒的制备及其对α-生育酚的包封作用和体外控制释放研究。
Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):145-52. doi: 10.1016/j.colsurfb.2011.02.020. Epub 2011 Feb 26.
10
Preparation, characterization, and in vitro antimicrobial assessment of nanocarrier based formulation of nadifloxacin for acne treatment.基于纳米载体的那氟沙星制剂用于痤疮治疗的制备、表征及体外抗菌评估
Pharmazie. 2011 Feb;66(2):111-4.